LLY

1,040.03

+0.29%↑

JNJ

243.3

-0.53%↓

ABBV

231.41

+1.75%↑

NVS

162.81

+1.21%↑

MRK

121.33

+1.83%↑

LLY

1,040.03

+0.29%↑

JNJ

243.3

-0.53%↓

ABBV

231.41

+1.75%↑

NVS

162.81

+1.21%↑

MRK

121.33

+1.83%↑

LLY

1,040.03

+0.29%↑

JNJ

243.3

-0.53%↓

ABBV

231.41

+1.75%↑

NVS

162.81

+1.21%↑

MRK

121.33

+1.83%↑

LLY

1,040.03

+0.29%↑

JNJ

243.3

-0.53%↓

ABBV

231.41

+1.75%↑

NVS

162.81

+1.21%↑

MRK

121.33

+1.83%↑

LLY

1,040.03

+0.29%↑

JNJ

243.3

-0.53%↓

ABBV

231.41

+1.75%↑

NVS

162.81

+1.21%↑

MRK

121.33

+1.83%↑

Search

STERIS PLC

Closed

SectorHealthcare

247.73 1.51

Overview

Share price change

24h

Current

Min

246.77

Max

248.89

Key metrics

By Trading Economics

Income

400K

193M

Sales

36M

1.5B

P/E

Sector Avg

35.208

121.746

EPS

2.53

Dividend yield

0.95

Profit margin

12.887

Employees

17,787

EBITDA

-121M

269M

Recommendations

By TipRanks

Recommendations

Buy

12 Months Forecast

+21% upside

Dividends

By Dow Jones

Dividend yield

Sector Avg

0.95%

2.26%

Next Earnings

13 May 2026

Next Dividend date

19 Mar 2026

Next Ex Dividend date

17 Feb 2026

Market Stats

By TradingEconomics

Market Cap

-1.9B

24B

Previous open

246.22

Previous close

247.73

Technical Score

By Trading Central

Confidence

Bearish Evidence

STERIS PLC Chart

Past performance is not a reliable indicator of future results.

Related News

4 Feb 2026, 21:30 UTC

Earnings

Steris Sees FY Adj EPS $10.15-Adj EPS $10.30 >STE

4 Feb 2026, 21:30 UTC

Earnings

Steris 3Q Rev $1.5B >STE

4 Feb 2026, 21:30 UTC

Earnings

Steris 3Q Adj EPS $2.53 >STE

4 Feb 2026, 21:30 UTC

Earnings

Steris 3Q Cont Ops EPS $1.96 >STE

5 Nov 2025, 21:30 UTC

Earnings

Steris 2Q Cont Ops EPS $1.94 >STE

5 Nov 2025, 21:30 UTC

Earnings

Steris 2Q Rev $1.5B >STE

5 Nov 2025, 21:30 UTC

Earnings

Steris 2Q Adj EPS $2.47 >STE

6 Aug 2025, 20:30 UTC

Earnings

Steris 1Q Adj EPS $2.34 >STE

6 Aug 2025, 20:30 UTC

Earnings

Steris 1Q Rev $1.4B >STE

14 May 2025, 20:30 UTC

Earnings

Steris Sees FY Adj EPS $9.90-Adj EPS $10.15 >STE

14 May 2025, 20:30 UTC

Earnings

Steris 4Q Rev $1.5B >STE

14 May 2025, 20:30 UTC

Earnings

Steris 4Q Adj EPS $2.74 >STE

Peer Comparison

Price change

STERIS PLC Forecast

Price Target

By TipRanks

21% upside

12 Months Forecast

Average 295.5 USD  21%

High 300 USD

Low 291 USD

Based on 4 Wall Street analysts offering 12 month price targets forSTERIS PLC - Dist in the last 3 months.

Rating Consensus

By TipRanks

Buy

4 ratings

2

Buy

2

Hold

0

Sell

Technical Score

By Trading Central

225 / 226.35Support & Resistance

Short Term

Bearish Evidence

Intermediate Term

Strong Bullish Evidence

Long Term

Strong Bullish Evidence

Financials

Selling and administration expenses

Operating expenses

Pre-tax profit

Sales

Cost of sales

Gross profit on sales

Interest expense on debt

EBITDA

Operating profit

$

About STERIS PLC

STERIS plc provides infection prevention products and services worldwide. It operates through three segments: Healthcare, Applied Sterilization Technologies (AST), and Life Sciences. The Healthcare segment offers cleaning chemistries and sterility assurance products; automated endoscope reprocessing system and tracking products; endoscopy accessories, washers, sterilizers, and other pieces of capital equipment for the operation of a sterile processing department; and equipment used directly in surgical tables, lights, and connectivity solutions, as well as equipment management services. It also provides capital equipment installation, maintenance, upgradation, repair, and troubleshooting services; preventive maintenance programs and repair services; instrument, devices, and endoscope repair and maintenance services; and custom process improvement consulting and outsourced instrument sterile processing services. The AST segment provides contract sterilization and testing services for medical device and pharmaceutical manufacturers through a network of contract sterilization and laboratory facilities, as well as integrated sterilization equipment and control systems to medical device manufacturers and research institutions. The Life Sciences segment designs, manufactures, and sells consumable products, such as pharmaceutical detergents, cleanroom disinfectants and sterilants, pharmaceutical grade and research sterilizers and washers, sterility assurance and maintenance products, vaporized hydrogen peroxide room decontamination systems and sterilizers, and high purity water and pure steam generators. This segment also offers equipment installation, maintenance, upgradation, repair, and troubleshooting services; and preventive maintenance programs and repair services. It serves its products and services to hospitals, other healthcare providers, and pharmaceutical manufacturers. The company was founded in 1985 and is headquartered in Mentor, Ohio.
help-icon Live chat